Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Neurol Neurosurg Psychiatry ; 74(8): 1080-4, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12876238

RESUMO

OBJECTIVES: This paper reports for the first time three cases of infection by HTLV-I via organ transplantation; all the organs coming from the same asymptomatic infected donor. The need is considered for the implementation of compulsory screenings for HTLV antibodies on organ donors and on blood banks. METHODS: The determination of antibodies for HTLV-I/II on samples of serum and cerebral spinal fluid from the patients and the donor was performed by enzyme immunoassay and western blot. Analysis of proviral DNA was performed by polymerase chain reaction. To detect changes in the sequence of amino acids, the tax gene was sequentiated, amplified, and compared with ATK prototype stocks. Spinal cord magnetic resonance imaging, cerebral spinal fluid, and somatosensory evoked potential studies were carried out in all patients. RESULTS: All three transplanted patients developed a myelopathy within a very short period of time. In all three patients and donor the virus belonged to the Cosmopolitan A subtype. The homology of HTLV-I sequences recovered from the patients and donor was 100% in all four cases. Proviral load was high in all three patients. The factors that certainly contributed to the infection in the first place, and the development of the disease later, were on the one hand the high proviral load and their immunosuppressed condition, and on the other the virus genotype, which proved to be an aggressive variant. However, the analysis of the histocompatibility antigen showed that two of the patients carried an haplotype that has been associated with a lower risk of developing this disease. CONCLUSIONS: It is argued that, although in Spain and other European countries there is not compulsory screening for HTLV antibodies because of the studies that show a low seroprevalence, in view of the cases here reported, and to avoid the serious consequences that such infection has on transplanted patients, compulsory screenings, both on organ donors and on blood banks, should be implemented.


Assuntos
Infecções por HTLV-I/diagnóstico , Transplante de Rim , Transplante de Fígado , Mielite/diagnóstico , Paraplegia/diagnóstico , Complicações Pós-Operatórias/diagnóstico , Doadores de Tecidos , Adulto , Feminino , Anticorpos Anti-HTLV-I/sangue , Infecções por HTLV-I/transmissão , Anticorpos Anti-HTLV-II/sangue , Humanos , Imunossupressores/administração & dosagem , Imunossupressores/efeitos adversos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Mielite/etiologia , Paraplegia/etiologia , Fatores de Risco , Medula Espinal/patologia
2.
An Esp Pediatr ; 48(2): 127-31, 1998 Feb.
Artigo em Espanhol | MEDLINE | ID: mdl-9580511

RESUMO

OBJECTIVE: The objective of this study was to determine the epidemiology of Mycoplasma pneumoniae infections at our hospital and to evaluate the prescription of macrolides to empirically treat respiratory infections in children. PATIENTS AND METHODS: A one year prospective study was performed. To find out the prevalence of M. pneumoniae infections, we obtained blood samples of 519 children attending our hospital out-patient department to determine M. pneumoniae IgG levels. In order to establish the incidence, IgM antibodies against M. pneumoniae were measured in 255 children admitted to the hospital showing clinical pictures compatible with this infection. RESULTS: In the first years of life, prevalence of M. pneumoniae infection was low. According to our study, only 3.3% of 1 year-old patients had M. pneumoniae antibodies. Antibody levels increased in children of 5 years or older. The highest rates, between 58.5% and 63.3%, were detected in patients between 8 and 12 years of age. The incidence rate (6.7%) was low among the children admitted. The most frequent clinical entity was pneumonia (82%). The highest rate of infection was found in children of 8 to 10 years. Symtomatology was mainly sub-acute. Crioagglutinins provided the most significant predictive value for etiological diagnosis. CONCLUSIONS: M. pneumoniae infections gain significance in patients over 5 years of age. In our environment, incidence of acute symptomatic infection is low. We consider that both age and presentation of acute respiratory processes should be taken into account when establishing empirical macrolide treatment in children.


Assuntos
Infecções por Mycoplasma/epidemiologia , Infecções por Mycoplasma/microbiologia , Mycoplasma pneumoniae/isolamento & purificação , Distribuição por Idade , Anticorpos Antibacterianos , Criança , Pré-Escolar , Feminino , Hospitais Pediátricos , Humanos , Imunoglobulina G/imunologia , Imunoglobulina M/imunologia , Lactente , Masculino , Infecções por Mycoplasma/imunologia , Prevalência , Estudos Prospectivos
3.
Rev Infect Dis ; 7(5): 700-1, 1985.
Artigo em Inglês | MEDLINE | ID: mdl-4059758

RESUMO

One hundred thirty cases of Q fever were seen in the Basque region of Spain between 1981 and 1984. Approximately 40% of these were related to epidemic outbreaks, and the remainder were isolated cases. The large majority of cases occurred in young men and women between 20 and 40 years of age. A seasonal peak coincided with lambing time in the region. Treatment had favorable outcome in each case, and no chronic disease was seen.


Assuntos
Febre Q/epidemiologia , Adolescente , Adulto , Idoso , Criança , Surtos de Doenças/epidemiologia , Métodos Epidemiológicos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Febre Q/diagnóstico , Estações do Ano , Espanha
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...